Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease
Nature Medicine2007Vol. 13(4), pp. 432–438
Citations Over TimeTop 1% of 2007 papers
Joseph El Khoury, Michelle Toft, Suzanne E. Hickman, Terry K. Means, Kinya Terada, Changiz Geula, Andrew D. Luster
Related Papers
- → Monocyte Chemoattractant Protein‐1 (CCL2) in Inflammatory Disease and Adaptive Immunity: Therapeutic Opportunities and Controversies(2003)235 cited
- → A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasis(2017)89 cited
- → Monocyte chemotactic protein (MCP)-1 (CCL2) and its receptor (CCR2) are elevated in chronic heart failure facilitating lung monocyte infiltration and differentiation which may contribute to lung fibrosis(2022)19 cited
- → A peptide-based near-infrared fluorescence probe for dynamic monitoring senile plaques in Alzheimer’s disease mouse model(2017)15 cited
- → 095 Monocyte chemotactic protein-1 (CCL2/ MCP-1) synthesis and rôle in idiopathic pulmonary arterial hypertension (IPAH)(2005)